-
Avicanna, Ei. Ventures Partner To Develop And Launch Functional Fungi-Based Products
Wednesday, July 20, 2022 - 8:41am | 464Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products has entered into an intellectual property licensing & royalty agreement with Ei.Ventures, Inc. to develop...
-
Ei.Ventures And Mycotopia To Merge Into New Psychedelic Mushroom Company
Friday, May 20, 2022 - 8:37am | 345Two companies in the psychedelics space have signed a definitive agreement to merge. Mycotopia Therapies Inc. (OTCPink: TPIA) and Ei.Ventures Inc. have executed a previously-announced agreement by which they’ll give birth to a new entity called PSLY.com, which will become the parent company...
-
Ei.Ventures To Host Psychedelic Therapies In Metaverse, Saying It's "The Only Way To Scale"
Thursday, January 13, 2022 - 5:05pm | 671Miami-based psychedelics startup Ei.Ventures announced this week that it has purchased a virtual land estate in The Sandbox, where clinicians will be able to host psychedelic therapy sessions in the metaverse, reported Forbes. The Sandbox is a monetized virtual world...
-
Psychedelics Stock Mycotopia On The Move Following LOI To Merge With Ei.Ventures In $360M Transaction
Wednesday, December 8, 2021 - 12:30pm | 643Medical psychedelics company Mycotopia Therapies Inc. (OTCPK: TPIA) reported Wednesday that it has signed a letter of intent to acquire botanical psilocybin pioneer, Ei.Ventures in a transaction valued at $360 million. When a definitive agreement is reached, the combined companies plan to work on...
-
Psychedelics Company Reaches $20M In Reg A Offering— Wants To Reach $50M
Wednesday, October 20, 2021 - 3:12pm | 230Emotional Intelligence Ventures, a company looking to develop a botanical approach to psychedelic medicines, announced that its Reg A has reached a milestone of $20 million. The Hawaii-based company announced a $50 million public stock offering using the Reg A+ Framework in March. This type of...
-
Psyched: MindMed's 2020 Financials, Psychedelics ETF Rebalancing, Country's First Psychedelics Masters Degree
Tuesday, April 6, 2021 - 11:39am | 1305MindMed Posts 2020 Financials, New MDMA Dosing Study and 18-MC Patent Application MindMed (OTCQB:MMEDF) released its full-year 2020 financial results. The company posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020. Its total assets at the end of the...
-
Exclusive: Ei. Ventures Launches $50M Reg A+
Tuesday, March 30, 2021 - 2:44pm | 844Emotional Intelligence Ventures, a company dedicated to research and production of botanical psychedelics, announced a public stock offering using the Reg A+ Framework. The company received qualification from the Securities and Exchange Commission to launch a Regulation A+ Tier 2 offering, which...